| Wafermine (ketamine) / iX Biopharma |
ACTRN12614000543684: The analgesic efficacy, tolerability, safety and pharmacokinetics of a sublingual wafer formulation of ketamine in burns patients undergoing painful dressing changes |
|
|
| Recruiting | 2 | 40 | | | Ix Biopharma Pty Ltd, Mr Eddy Lee
| Burns | | | | |
NCT02199678: A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction |
|
|
| Completed | 2 | 120 | US | Placebo, ketamine 25 mg, ketamine 35 mg, ketamine 50 mg | Lotus Clinical Research, LLC, iX Biopharma Ltd. | Pain | 11/14 | 11/14 | | |
NCT02356965: Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction |
|
|
| Completed | 2 | 80 | US | Ketamine, Placebo (for Ketamine), Sugar pill | iX Biopharma Ltd., Jean Brown Research, Lotus Clinical Research, LLC | Pain | 02/15 | 02/15 | | |
NCT02541396: A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy |
|
|
| Completed | 2 | 72 | US | Wafermine, Sublingual ketamine, Oxycodone, Placebo | iX Biopharma Ltd., Jean Brown Research | Acute Pain | 12/15 | 12/15 | | |
NCT02857361: Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols. |
|
|
| Completed | 2 | 10 | RoW | Sublingual ketamine wafers, Wafermine | iX Biopharma Ltd. | Pain | 08/16 | 08/16 | | |
NCT03246971: Study of Wafermineâ„¢ for Post-bunionectomy or Abdominoplasty Pain |
|
|
| Completed | 2 | 125 | US | Wafermineâ„¢ 50 mg, Wafermineâ„¢ 75 mg, Placebos, Wafermineâ„¢ 25 mg | iX Biopharma Ltd. | Acute Pain, Bunion, Abdominoplasty | 07/18 | 07/18 | | |
